| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2022 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 754 | $100.00 | $75,400.00 | -4.3% | +0.6% | -5.2% | |
| Jun 27, 2022 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 5,000 | $236.79 | $1,183,950.00 | -88.1% | -15.7% | -10.8% | |
| Jun 24, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 215,000 | $324.31 | $69,726,323.87 | - | -4.2% | +41.8% | |
| Jun 23, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $311.05 | $63,764,750.24 | - | -4.9% | +47.6% | |
| Jun 23, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 20,000 | $2.53 | $50,600.00 | - | - | - | |
| Jun 22, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $306.84 | $64,435,610.54 | - | -1.3% | +50.1% | |
| Jun 21, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 10,000 | $2.54 | $25,400.00 | - | - | - | |
| Jun 21, 2022 | HIMS Hims & Hers Health, Inc. | O'Keefe Lynne Chou | Director | Sell | 10,045 | $4.35 | $43,695.75 | -100% | +32.0% | +92.2% | |
| Jun 21, 2022 | ALKS Alkermes Plc. | Nichols Christian Todd48 | SVP, Chief Commercial Officer | Sell | 7,474 | $28.26 | $211,203.28 | -26.2% | -17.2% | +19.1% | |
| Jun 17, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 5,000 | $2.72 | $13,600.00 | - | - | - | |
| Jun 17, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 5,512 | $32.05 | $176,681.65 | -5.2% | -6.9% | +74.6% | |
| Jun 17, 2022 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L.60 | President And CEO | Sell | 4,552 | $4.99 | $22,719.03 | -2.3% | +34.3% | -74.6% | |
| Jun 17, 2022 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 256 | $4.90 | $1,254.40 | -0.5% | +34.3% | -74.6% | |
| Jun 16, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 25,000 | $2.75 | $68,625.00 | - | - | - | |
| Jun 16, 2022 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $215.58 | $1,293,471.94 | -5.0% | +0.7% | +5.8% | |
| Jun 16, 2022 | CBSTF Cannabist Co Holdings Inc. | Vita Nicholas | CEO | Buy | 8,000 | $1.47 | $11,741.09 | +0.4% | - | - | |
| Jun 15, 2022 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 386 | $62.87 | $24,267.82 | -0.6% | +31.4% | +39.5% | |
| Jun 14, 2022 | HIMS Hims & Hers Health, Inc. | Maltz Jules A.72 | Director, 10% Owner | Buy | 75,000 | $3.66 | $274,493.50 | +74.0% | +73.4% | +126.4% | |
| Jun 14, 2022 | AQST Aquestive Therapeutics, Inc. | Boyd Peter E.84 | Svp-bus. Process &Info. Tech. | Buy | 5,000 | $0.81 | $4,050.00 | +9.2% | +72.5% | +164.7% | |
| Jun 14, 2022 | IRWD Ironwood Pharmaceuticals Inc | Kessler Marla L | Director | Sell | 7,610 | $11.65 | $88,656.50 | -8.3% | -3.8% | -3.5% | |
| Jun 13, 2022 | AMRN Amarin Corp Plc\uk | Wold Olsen Per | Director | Buy | 55,000 | $1.69 | $92,730.00 | +58.5% | -18.2% | -24.7% | |
| Jun 13, 2022 | BMY Bristol Myers Squibb Co | Caforio Giovanni59 | Board Chair And CEO | Sell | 30,000 | $74.04 | $2,221,200.00 | -5.2% | -1.0% | -10.7% | |
| Jun 13, 2022 | ORGO Organogenesis Holdings Inc. | Erani Albert79 | 10% Owner | Sell | 30,000 | $4.89 | $146,835.71 | - | -23.6% | -13.2% | |
| Jun 13, 2022 | ORGO Organogenesis Holdings Inc. | Erani Albert79 | 10% Owner | Sell | 30,000 | $4.89 | $146,835.71 | - | -23.6% | -13.2% | |
| Jun 10, 2022 | ZTS Zoetis Inc. | Reed Willie M55 | Director | Sell | 1,855 | $162.31 | $301,085.05 | -21.5% | -1.7% | +1.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.